| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | Klencke Barbara | Director | Dec 14, 2023 | Buy | $5.08 | 5,000 | 25,400 | 30,000 | Dec 18, 2023, 06:01 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Medical Officer | Jul 01, 2022 | Option Exercise | $55.00 | 10,000 | 550,000 | 0 | Jul 01, 2022, 04:43 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Medical Officer | Jul 01, 2022 | Option Exercise | $55.00 | 5,000 | 275,000 | 0 | Jul 01, 2022, 04:43 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Development Officer | Aug 18, 2020 | Buy | $12.25 | 3,325 | 40,738 | 5,000 | Aug 18, 2020, 08:16 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Development Officer | Aug 18, 2020 | Buy | $12.22 | 5,950 | 72,710 | 10,000 | Aug 18, 2020, 08:16 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Development Officer | Aug 22, 2019 | Buy | $0.45 | 54,000 | 24,295 | 54,000 | Aug 26, 2019, 05:07 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Development Officer | Aug 22, 2019 | Buy | $0.43 | 67,000 | 28,964 | 67,000 | Aug 26, 2019, 05:07 PM | |
| SRRA | Sierra Oncology, Inc. | Klencke Barbara | Chief Development Officer | Aug 23, 2019 | Buy | $0.44 | 108,000 | 47,380 | 162,000 | Aug 26, 2019, 05:07 PM |
Menu